Research Frontiers (NASDAQ:REFR) Posts Earnings Results

Research Frontiers (NASDAQ:REFR) released its earnings results on Thursday. The technology company reported ($0.02) EPS for the quarter, FiscalAI reports. The business had revenue of $0.14 million for the quarter. Research Frontiers had a negative net margin of 182.60% and a negative return on equity of 122.96%.

Here are the key takeaways from Research Frontiers’ conference call:

• Payments and revenue recognition were temporarily slowed by ongoing French rehabilitation proceedings involving licensee Gauzy, and a May 12 French court hearing could produce outcomes ranging from continuation to liquidation, creating short-term uncertainty.
• Management reports the flow of funds is beginning to normalize (including a meaningful payment from Vision Systems), and they view approval of Gauzy Vision Systems’ continuation plan as the most likely and constructive outcome.
• Research Frontiers strengthened its balance sheet in Q1—cash and cash equivalents rose to approximately $1.28 million (from ~$664k at year-end 2025), the company remains debt-free, and operating and R&D expenses declined.
• Q1 reported revenues were weaker year-over-year largely due to ASC 606 timing effects and the non-recurrence of an upfront 2025 license payment, while GAAP royalty recognition rules smooth minimum royalties across quarters.
• Underlying commercial activity remains active with sequential increases in automotive and aircraft royalties, ongoing aerospace deliveries, advancing architectural retrofit initiatives, and encouraging progress on black SPD technology that could expand addressable markets.

Research Frontiers Stock Down 9.5%

Shares of REFR traded down $0.08 during trading hours on Friday, reaching $0.75. 74,905 shares of the company traded hands, compared to its average volume of 34,434. Research Frontiers has a 12 month low of $0.75 and a 12 month high of $2.70. The company’s fifty day moving average price is $0.95 and its two-hundred day moving average price is $1.29. The company has a market capitalization of $26.21 million, a price-to-earnings ratio of -12.57 and a beta of 0.54.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Research Frontiers in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Research Frontiers currently has an average rating of “Sell”.

Hedge Funds Weigh In On Research Frontiers

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Raymond James Financial Inc. grew its stake in shares of Research Frontiers by 151.5% in the second quarter. Raymond James Financial Inc. now owns 41,337 shares of the technology company’s stock worth $68,000 after acquiring an additional 24,902 shares during the last quarter. XTX Topco Ltd purchased a new stake in Research Frontiers during the 4th quarter valued at about $28,000. Finally, Virtu Financial LLC bought a new stake in Research Frontiers during the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 11.91% of the company’s stock.

Research Frontiers Company Profile

Research Frontiers Inc (NASDAQ:REFR) is a materials science company specializing in the development and licensing of its proprietary SPD-Smart™ light control film. This patented Suspended Particle Device technology enables electronic tinting of glass to provide variable light transmission, glare reduction and solar heat management. SPD-Smart films are designed for integration into architectural windows, automotive sunroofs and skylights, as well as aerospace and specialty applications.

The company’s core business model revolves around licensing its SPD technology and supplying the functional film to manufacturing partners.